But there are facts, law and precedent on point, which are worth examining. First, we can start with 23andMe’s privacy statement, which is—to their credit—strong. In general, data can be ...

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...

Amy Nordrum, executive editor, and Charlotte Jee, news editor. Each year, MIT Technology Review publishes an annual list of the top ten breakthrough technologies that will have the greatest impact on how we live and work in the future.

The recent compromise of Cyberhaven’s Chrome extension appears to be part of a broad campaign that started over a year ago.

23andMe is cutting 40% of its staff Genetic ... Chief Financial Officer Matt Friend said in December. On January 10, Google laid off hundreds of workers in its central engineering division and ...

The ongoing hacking spree has compromised at least 25 Chrome extensions, potentially affecting over two million users. Cyberhaven, a data protection company, fell victim to the attack.

A widespread hacking campaign targeting Chrome extensions has compromised at least 25 extensions, potentially impacting over two million users worldwide. The attack, which was first reported by data protection company Cyberhaven on December 26,

The IPO market has been largely dormant since late 2021 as rising inflation and rising interest rates pushed investors out of risk. According to a report from Rock Health, few tech companies have gone public since then, and no digital health companies held an IPO in 2023.